ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

It’s Official : PRI Wins Massive FCRF Contract ; DMS Keeps Library, Lands Computer Servicea

September 18, 1987

DCBDC To Contract For CA Agents In Vaccine Testing

November 15, 1991

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

NCI Picks Duke To Lead caBIG’s Knowledge Center For Clinical Trials.

July 3, 2008

In Brief; Weicker May Be Next Chairman Of Senate Health Subcommittee Following Harrison Schmitt’s Defeat

November 12, 1982